Atlas Trials

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

Clinical trial NCT01898286 · TERMINATED

Trial details

NCT number
NCT01898286
Sponsor
Andromeda Biotech Ltd.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2013-10-01
Primary completion
2014-09-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.